EUVIMEDEUVIMED entdecken
Crossref

Neovascular age-related macular degeneration trial innovation remains vascular endothelial growth factor-centred despite therapeutic diversification

Lidetian Hu, Haixing Cao, Xiang Ma iD

Graefe's Archive for Clinical and Experimental Ophthalmology · 10.08.2026

DOI: 10.1007/s00417-026-07447-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Graefe's Archive for Clinical and Experimental Ophthalmology, online erschienen am 10.08.2026. Verfasst von Lidetian Hu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, The First Affiliated Hospital of Dalian Medical University, 222 Zhongshan Road, Dalian City, Liaoning Province, China. Die Arbeit nennt 5 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Anti-VEGF therapyClinical trialsNeovascular age-related macular degenerationTherapeutic innovationVascular endothelial growth factor

Autor:innen und Institutionen

  • Department of Ophthalmology, The First Affiliated Hospital of Dalian Medical University, 222 Zhongshan Road, Dalian City, Liaoning Province, China.
  • Department of Ophthalmology, The First Affiliated Hospital of Dalian Medical University, 222 Zhongshan Road, Dalian City, Liaoning Province, China. eyedl220@163.com.

ORCID-Profile: Xiang Ma

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Hu, L., Cao, H., & Ma, X. (2026). Neovascular age-related macular degeneration trial innovation remains vascular endothelial growth factor-centred despite therapeutic diversification. Graefe's Archive for Clinical and Experimental Ophthalmology. https://doi.org/10.1007/s00417-026-07447-2

Vancouver

Hu L, Cao H, Ma X. Neovascular age-related macular degeneration trial innovation remains vascular endothelial growth factor-centred despite therapeutic diversification. Graefe's Archive for Clinical and Experimental Ophthalmology. 2026. doi:10.1007/s00417-026-07447-2

BibTeX
@article{Hu2026,
  author = {Hu, Lidetian and Cao, Haixing and Ma, Xiang},
  title = {Neovascular age-related macular degeneration trial innovation remains vascular endothelial growth factor-centred despite therapeutic diversification},
  journal = {Graefe's Archive for Clinical and Experimental Ophthalmology},
  year = {2026},
  doi = {10.1007/s00417-026-07447-2}
}
Kostenlos starten →